Reporter Aug 7 2020

August 11, 2020

Risk marker for repeat sinus surgery

An inflammatory factor in mucus could be a biomarker of treatment-resistant chronic sinusitis used to determine which patients are at risk for repeat sinus surgery.

By Leigh MacMillan
August 10, 2020

A step toward cancer prevention

A computational technique that combines the effect of multiple genomic variants has the potential to identify high-risk individuals for cancer prevention.

By Bill Snyder
August 6, 2020

ID of ‘stomach flu’ culprit

Identifying the norovirus genotypes associated with more severe infections in children could guide strain selection for candidate norovirus vaccines.

By Leigh MacMillan
August 6, 2020

Grant supports research on abnormal brain aging

With the aid of an $18.2 million, five-year grant renewal from the National Institute on Aging, the Vanderbilt Memory and Aging Project (VMAP) will advance interdisciplinary research into abnormal brain aging and cognitive decline in older adults, with continuing emphasis on the role of blood flow changes in the heart and brain.

By Paul Govern
August 6, 2020

The importance of estrogen cycles

Deborah Lannigan and colleagues identify a key regulator of the estrogen receptor and suggest that its downregulation by oral contraceptives may increase oxidative stress and DNA damage, a common cause of cancer.

By Sarah E. Glass
August 6, 2020

Appendix cancer survival in young patients varies by race: study

The first study of appendiceal cancer patterns and survival by race/ethnicity among patients younger than 50 in the U.S. showed survival disparities.

By Leigh MacMillan
August 6, 2020

Study gauges specific site stomach cancer risks among ethnic groups

Non-white Americans, especially Asian Americans, are at disproportionately higher risk for gastric cancer compared to non-Hispanic white Americans. A new study breaks down this risk according to specific ethnicities and locations within the stomach.
By Tom Wilemon
August 6, 2020

Davis named senior medical director for VICC Cancer Care Network and Strategy

Nancy Davis, MD, has been named senior medical director for VICC Cancer Care Network and Strategy, a new leadership position at Vanderbilt-Ingram Cancer Center responsible for expanding cancer clinics within and beyond the Middle Tennessee catchment area.
By Tom Wilemon
August 6, 2020

Goff named executive medical director for the VICC Cancer Patient Care Center

Laura Goff, MD, MSCI, associate professor of Medicine, has been named the executive medical director for the Vanderbilt-Ingram Cancer Center (VICC) Cancer Patient Care Center.
By Tom Wilemon
August 6, 2020

Extracorporeal life support program honored by ELSO

Vanderbilt University Medical Center’s extracorporeal life support (ECLS) program has received the gold level award for excellence in life support from the Extracorporeal Life Support Organization (ELSO).
By Matt Batcheldor
August 6, 2020

Team to create customizable cochlear implant programming

A team of Vanderbilt University and Vanderbilt University Medical Center researchers has received a $3.1 million National Institutes of Health (NIH) grant to develop advanced, patient-specific cochlear implant stimulation models for customized implant programming.
By VUMC News and Communications
August 6, 2020

Patrick receives award for children’s health research

Stephen Patrick, MD, MPH, MS, director of the Vanderbilt Center for Child Health Policy, has been awarded the fifth annual Gale and Ira Drukier Prize in Children’s Health Research.
By Christina Echegaray
August 6, 2020

Study finds Medicare Part D favors generic drugs over brand-name counterparts

Contrary to previous media reports, a new study led by Vanderbilt University Medical Center researchers finds that Medicare Part D prescription drug insurance plans largely favor generic drugs over brand-name counterparts.
By Jake Lowary